Geographic · Trial modifications

In North America offices — Trial modifications

Citigroup In North America offices — Trial modifications decreased by 80.0% to $8.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 42.9%, from $14.00M to $8.00M. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ1 2023
Last reportedQ1 2026May 7, 2026

How to read this metric

Higher values indicate a larger portion of the portfolio is under stress and requiring intervention.

Detailed definition

The total monetary value of financing receivables that are currently in a trial modification program. This reflects the...

Peer comparison

Standard metric for large consumer lenders; peers often disclose this under 'troubled debt restructuring' or 'loan modification' disclosures.

Metric ID: c_segment_in_north_america_offices_trial_modifications

Historical Data

11 periods
 Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$25.00M$15.00M$12.00M$11.00M$11.00M$8.00M$11.00M$14.00M$20.00M$40.00M$8.00M
QoQ Change-40.0%-20.0%-8.3%+0.0%-27.3%+37.5%+27.3%+42.9%+100.0%-80.0%
YoY Change-56.0%-26.7%-33.3%+27.3%+81.8%+400.0%-42.9%
Range$8.00M$40.00M
CAGR-36.6%
Avg YoY Growth+50.0%
Median YoY Growth-26.7%

Frequently Asked Questions

What is Citigroup's in north america offices — trial modifications?
Citigroup (C) reported in north america offices — trial modifications of $8.00M in Q1 2026.
How has Citigroup's in north america offices — trial modifications changed year-over-year?
Citigroup's in north america offices — trial modifications decreased by 42.9% year-over-year, from $14.00M to $8.00M.
What does in north america offices — trial modifications mean?
The total dollar value of loans currently in a trial restructuring program.